Challenges in drug development for functional gastrointestinal disorders. Part II: Visceral pain

Neurogastroenterology and Motility

Volumn 18, Issue 5, 2006, Pages 354-360

  Andresen, V ^a   Camilleri, M ^a,b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Barostat; Brain imaging; Pharmacogenomics; Pharmacokinetics; Sensation; Thresholds

Indexed keywords

ALOSETRON; ALVIMOPAN; AMITRIPTYLINE; ASIMADOLINE; BIOLOGICAL MARKER; CHOLECYSTOKININ; DESIPRAMINE; FENTANYL; FLUOXETINE; MIANSERIN; MORPHINE; OCTREOTIDE; ONDANSETRON; OTILONIUM BROMIDE; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; DRUG EFFICACY; DYSPEPSIA; ENTEROPATHY; GASTROINTESTINAL DISEASE; HUMAN; METABOLISM; NEUROIMAGING; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; REVIEW; SENSATION; VISCERA; VISCERAL PAIN;

ANIMALS; BIOLOGICAL MARKERS; BRAIN MAPPING; CLINICAL TRIALS; DRUG DESIGN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; PAIN; RESEARCH DESIGN; VISCERA;

EID: 33645799070     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00779.x     Document Type: Review

References (38)

1. Delgado-Aros S Camilleri M Visceral hypersensitivity J Clin Gastroenterol 2005 39 Suppl. 5 S194 203
2. Camilleri M Talley NJ Pathophysiology as a basis for understanding symptom complexes and therapeutic targets Neurogastroenterol Motil 2004 16 135 42
3. Delvaux M Louvel D Mamet JP Campos-Oriola R Frexinos J Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome Aliment Pharmacol Ther 1998 12 849 55
4. Mayer EA Berman S Derbyshire SW et al. The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients Aliment Pharmacol Ther 2002 16 1357 66
5. Delgado-Aros S Chial HJ Camilleri M et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans Am J Physiol Gastrointest Liver Physiol 2003 284 G558 66
6. Lembo T Naliboff BD Matin K et al. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids Pain 2000 87 137 47
7. Jackson JL O'Malley PG Tomkins G Balden E Santoro J Kroenke K Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis Am J Med 2000 108 65 72
8. Drossman DA Toner BB Whitehead WE et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 2003 125 19 31
9. Tanum L Malt UF A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin Scand J Gastroenterol 1996 31 318 25
10. Quartero A Meineche-Schmidt V Muris J Rubin G de Wit N Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome Cochrane Database Syst Rev 2005 CD003460
11. Mertz H Fass R Kodner A Yan-Go F Fullerton S Mayer EA Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia Am J Gastroenterol 1998 93 160 5
12. Chial HJ Camilleri M Burton D Thomforde G Olden KW Stephens D Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health Am J Physiol Gastrointest Liver Physiol 2003 284 G130 7
13. Kuiken SD Tytgat GN Boeckxstaens GE The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study Clin Gastroenterol Hepatol 2003 1 219 28
14. Willis WD Jr. Westlund KN The role of the dorsal column pathway in visceral nociception Curr Pain Headache Rep 2001 5 20 6
15. Whitehead WE Palsson OS Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception Gastroenterology 1998 115 1263 71
16. Corsetti M Cesana B Bhoori S Basilisco G Rectal hyperreactivity to distention in patients with irritable bowel syndrome: role of distention rate Clin Gastroenterol Hepatol 2004 2 49 56
17. Cremonini F Houghton LA Camilleri M et al. Barostat testing of rectal compliance in humans: comparison and reproducibility of measurements across two centres Neurogastroenterol Motil 2005 17 810 20
18. Bradette M Delvaux M Staumont G Fioramonti J Bueno L Frexinos J Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone Dig Dis Sci 1994 39 1171 8
19. Berman S Munakata J Naliboff BD et al. Gender differences in regional brain response to visceral pressure in IBS patients Eur J Pain 2000 4 157 72
20. Mohr C Binkofski F Erdmann C Buchel C Helmchen C The anterior cingulate cortex contains distinct areas dissociating external from self-administered painful stimulation: a parametric fMRI study Pain 2005 114 347 57
21. Drossman DA Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists Gut 2005 54 569 73
22. Andresen V Bach D Poellinger A et al. Cerebral response patterns to subliminal and supraliminal rectal stimuli and to auditory stimuli in irritable bowel syndrome Neurogastroenterol Motil 2005 17 827 37
23. Whitehead W Diamant N Meyer K et al. Pain thresholds measured by the barostat predict the severity of clinical pain in patients with irritable bowel syndrome Gastroenterology 1998 114 Pt 2 A859
24. Camilleri M Pharmacogenomics and functional gastrointestinal disorders Pharmacogenomics 2005 6 491 501
25. Gonenne J Camilleri M Ferber I et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study Clin Gastroenterol Hepatol 2005 3 784 91
26. Holtmann G Siffert W Grote E et al. G-protein mediated receptor-cell-coupling as a predictor for the long term response to treatment in patients with functional dyspepsia Gastroenterology 2003 124 Suppl. 1 A80
27. Yeo A Boyd P Lumsden S et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women Gut 2004 53 1452 8
28. Camilleri M Atanasova E Carlson PJ et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome Gastroenterology 2002 123 425 32
29. Naliboff BD Berman S Chang L et al. Sex-related differences in IBS patients: central processing of visceral stimuli Gastroenterology 2003 124 1738 47
30. Hammer J Phillips SF Talley NJ Camilleri M Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome Aliment Pharmacol Ther 1993 7 543 51
31. Czimmer J Suto G Kiraly A Mozsik G Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome J Physiol Paris 2001 95 153 6
32. Sabate JM Gorbatchef C Flourie B Jian R Coffin B Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects Neurogastroenterol Motil 2002 14 689 95
33. Delvaux M Beck A Jacob J Bouzamondo H Weber FT Frexinos J Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome Aliment Pharmacol Ther 2004 20 237 46
34. Bharucha AE Camilleri M Zinsmeister AR Hanson RB Adrenergic modulation of human colonic motor and sensory function Am J Physiol 1997 273 Pt 1 G997 1006
35. Bouin M Plourde V Boivin M et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds Gastroenterology 2002 122 1771 7
36. Hammer HF Phillips SF Camilleri M Hanson RB Rectal tone, distensibility, and perception: reproducibility and response to different distensions Am J Physiol 1998 274 Pt 1 G584 90
37. Mertz H Naliboff B Munakata J Niazi N Mayer EA Altered rectal perception is a biological marker of patients with irritable bowel syndrome Gastroenterology 1995 109 40 52
38. Naliboff BD Munakata J Fullerton S et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome Gut 1997 41 505 12